Beigene
Beigene, a leading biotechnology company headquartered in China (CN), is at the forefront of developing innovative therapies for cancer and other serious diseases. Founded in 2010, Beigene has rapidly expanded its operations across major regions, including North America, Europe, and Asia, establishing a strong global presence in the biopharmaceutical industry. The company is renowned for its robust pipeline of targeted therapies and immuno-oncology products, with a focus on precision medicine. Notable achievements include the successful development of its flagship drug, Brukinsa, which has gained recognition for its efficacy in treating various forms of blood cancer. Beigene's commitment to research and development, coupled with strategic partnerships, positions it as a key player in the competitive landscape of oncology therapeutics.
DitchCarbon Score
How does Beigene's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Beigene's score of 35 is higher than 88% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Beigene's reported carbon emissions
In 2023, Beigene reported total carbon emissions of approximately 555,892,000 kg CO2e. This figure includes 2,463,000 kg CO2e from Scope 1 emissions, which encompass direct emissions from owned or controlled sources, and 76,465,000 kg CO2e from Scope 2 emissions, related to indirect emissions from the generation of purchased electricity. The majority of their emissions, about 476,965,000 kg CO2e, fall under Scope 3, which includes emissions from the entire value chain, such as purchased goods and services (333,844,000 kg CO2e) and capital goods (97,211,000 kg CO2e). Beigene has not disclosed specific reduction targets or initiatives as part of their climate commitments. However, they continue to monitor and report their emissions across all three scopes, demonstrating a commitment to transparency in their environmental impact. The company’s emissions per kg of internally-manufactured commercial product for 2023 was reported at 1,560 kg CO2e, indicating a focus on improving efficiency in their production processes. Overall, Beigene's emissions data reflects their ongoing efforts to understand and manage their carbon footprint, although specific reduction strategies or targets have not been outlined.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|
| Scope 1 | 535,000 | 000,000 | 000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 5,929,000 | 0,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Beigene is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
